The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.

The present invention relates to compounds for the treatment of mTOR (mammalian Target Of Rapamycin) pathway related diseases. Specifically, the present invention relates to the use of aminoactonitrile derivatives (AADs) in the treatment of mTOR pathway related diseases.

Compounds of formula (I), wherein R.sub.1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.

Compounds of formula (I), wherein R.sub.1 is as defined in the claims, exhibit COMT enzyme inhibiting activity and are thus useful as COMT inhibitors. Methods of treatment and pharmaceutical dosage forms are also disclosed.

Compounds of the formula (I), in which the substituents are as defined in claim 1, are suitable for use as nematicides. ##STR00001##

Compounds of the formula (I), in which the substituents are as defined in claim 1, are suitable for use as nematicides. ##STR00001##

The present invention relates to the technical field of medicine, and specifically relates to the carboxylic acid compound represented by the chemical formula I or chemical formula II, and a pharmaceutically acceptable salt, a prodrug, and a solvate thereof, and a method for preparation thereof, as well as a pharmaceutical composition containing the described substances, and a use thereof.

##STR00001##

In one aspect, the invention provides a method of promoting a carbon-sulfur bond forming reaction. In certain embodiments, the reaction comprises cross-coupling of a(n) (hetero)aryl halide with a thiol to form the carbon-sulfur bond, wherein the method is promoted by light irradiation in the absence of a photocatalyst. In other embodiments, the cross-coupling reaction can be promoted through visible light irradiation, including sunlight.

In one aspect, the invention provides a method of promoting a carbon-sulfur bond forming reaction. In certain embodiments, the reaction comprises cross-coupling of a(n) (hetero)aryl halide with a thiol to form the carbon-sulfur bond, wherein the method is promoted by light irradiation in the absence of a photocatalyst. In other embodiments, the cross-coupling reaction can be promoted through visible light irradiation, including sunlight.

A method for preparing a composite material, including the following steps: providing metal oxide nanoparticles and a polyaromatic compound having a structure represented by Formula I,

##STR00001##

where, Ar.sub.1, Ar.sub.2, Ar.sub.3, and Ar.sub.4 are selected from aromatic rings; X.sub.1, X.sub.2, and X.sub.3 are selected from active groups configured for binding with the metal oxide nanoparticles, each of R.sub.1, R.sub.2, and R.sub.3 independently contains at least one of alkylene, amine, —N═N—, alkenyl, alkynyl, and phenyl, and each of m, n, and y is independently selected from 0 or positive integers; dispersing the polyaromatic compound and the metal oxide nanoparticles in a solvent to yield a mixed solution; and heating the mixed solution to yield the composite material. A composite material includes: a polyaromatic compound and metal oxide nanoparticles. The polyaromatic compound is connected to the metal oxide nanoparticles. The polyaromatic compound has a structure represented by Formula I.